Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

BioMarin

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of BioMarin's 2012 metabolic sales performance.

Shire rumoured to be pursuing Actelion

Shire rumoured to be pursuing Actelion Other transactions including rare disease companies of late include Horizon Pharma's $1.1bn deal to buy urea cycle disorder specialist Hyperion Therapeutics and BioMarin $840m purchase of Prosensa in order

Sanofi and Amgen poised for cholesterol drug sales

Sanofi and Amgen poised for cholesterol drug sales BioMarin last year. .

Pharma deals in May 2015

Pharma deals in May 2015 Sanofi has been adept in this area with its previous access to a PRV for Alirocumab for dyslipidaemia (in partnership with Regeneron who had originally purchased the PRV from Biomarin) for

Sanofi pays $245m for FDA priority review voucher

Sanofi pays $245m for FDA priority review voucher It is not the first time has shelled out to accelerate development of one of its products, having paid $67.5m to BioMarin last year for a PRV that allowed its

Alexion boosts rare disease portfolio with $8.4bn Synageva buy

Alexion boosts rare disease portfolio with $8.4bn Synageva buy Meanwhile, Horizon Pharma stumped up $1.1bn for urea cycle disorder specialist Hyperion Therapeutics and BioMarin bought Prosensa for $840m, gaining access to its muscular dystrophy drug drisapersen. .

[ Previous 5 results ] 9 10 11 12 13 14 15 16 17 18 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics